Jane Street »

Acrivon Therapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2025-09-30 $524k 289k 1.81
2025-06-30 $371k 312k 1.19
2024-06-30 $178k 31k 5.80

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs (GLD)
Apple Call Option (AAPL)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Microsoft Corporation Call Option (MSFT)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Strategy Cl A New (MSTR)
Broadcom Call Option (AVGO)
Amazon Call Option (AMZN)

View all positions for Jane Street

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Citadel Advisors
Wellington Management Company
Vanguard Group
Renaissance Technologies
Acorn Capital Advisors
UBS Group
BlackRock
Two Sigma Investments
Jane Street
Geode Capital Management
Millennium Management
Marshall Wace
Two Sigma Advisers

View all funds holding Acrivon Therapeutics